Public offerings

FRISCO, Texas and BURLINGTON, Mass., Nov. 12, 2026 /PRNewswire/ -- Keurig Dr Pepper Inc. (NASDAQ:KDP) ("KDP" or the "Company") today announced the pricing of its previously announced underwritten public offering of 57,971,015 shares of its common stock, par value $0.01 per share (the "Offering"), at a price to the public of $34.50 per share. KDP's common stock is listed on the Nasdaq Global Select Market under the symbol "KDP."KDP has granted the underwriters of the Offering a 30-day option to purchase up to an additional 8,695,652 shares of common stock, at the same price per share as the other shares of common stock purchased by the underwriters in the Offering. The Offering is expected to

Vir Biotechnology, Inc. (NASDAQ:VIR), a clinical-stage biopharmaceutical company focused on powering the immune system to transform lives by discovering and developing medicines for serious infectious diseases and cancer, today announced the pricing of its underwritten public offering of 15,000,000 shares of its common stock at a price to the public of $10.00 per share. The gross proceeds to Vir Biotechnology from the offering are expected to be $150 million, before deducting underwriting discounts and commissions and offering expenses. In addition, Vir Biotechnology has granted the underwriters a 30-day option to purchase up to an additional 2,250,000 shares of its common stock at the publ

Strong Cash Conversion and Continued Earnings Growth Full-Year 2026 Guidance Reaffirmed Afya Limited (NASDAQ:AFYA, B3: A2FY34)) ("Afya" or the "Company"), the leading medical education group and medical practice solutions provider in Brazil, reported today its financial and operating results for the three and nine-month period, which ended September 30, 2026 (third quarter 2026). Financial results are expressed in Brazilian Reais and are presented in accordance with International Financial Reporting Standards ("IFRS"). These materials are not an offer for sale of securities in the United States, nor a solicitation of votes or proxies. The securities have not been registered under the U.

JILIN, China, Nov. 12, 2026 /PRNewswire/ -- Zhengye Biotechnology Holding Limited (NASDAQ:ZYBT) (the "Company" or "Zhengye"), a veterinary vaccine manufacturer that encompasses research, development, manufacturing, and sales of veterinary vaccines, with a focus on livestock vaccines in China, today announced its unaudited financial results for the six months ended June 30, 2026. Mr. Songlin Song, co-chief executive officer of Zhengye, remarked, "During the first half of fiscal year 2026, we continued to enhance profitability through disciplined cost management and operational efficiency. Despite the decline in net revenue and gross profit, we are encouraged by the improvement in our gross pr

Thirteen Recent Acquisitions Totaling $45.5 Million of Core Appalachia and Haynesville Mineral and Royalty Interests Record Production of 71.3 MMcfe/d for the Third Quarter 2026, Up 10% Year-Over-Year and 2% Compared to the Second Quarter 2026 Declared Dividend of $0.50 Per Share ($2.00 Annualized) WhiteHawk Minerals Corp. (NYSE:WHK) ("WhiteHawk" or the "Company") today announced the signing of $45.5 million of natural gas mineral and royalty acquisitions since August 13, 2026, as well as operating and financial results for the third quarter ended September 30, 2026. WhiteHawk will host a conference call and webcast to discuss its results for the third quarter of 2026 on November 13,

WILMINGTON, N.C., Nov. 12, 2026 (GLOBE NEWSWIRE) -- Live Oak Bancshares, Inc. (NYSE:LOB) ("Live Oak" or the "Company") announced the closing of its previously announced underwritten offering of 4,000,000 depositary shares, each representing a 1/40th interest in a share of its 8.750% Fixed Rate Series B Non-Cumulative Perpetual Preferred Stock (the "Series B Preferred Stock"), with a liquidation preference of $25 per depositary share. As a result of the public offering, Live Oak received proceeds of approximately $96,250,000, net of estimated expenses and underwriting discounts and commissions. Morgan Stanley & Co. LLC; Keefe, Bruyette & Woods, A Stifel Company; RBC Capital Markets, LLC; a

CAMBRIDGE, Mass., Nov. 12, 2026 (GLOBE NEWSWIRE) -- Prime Medicine, Inc. (NASDAQ:PRME), a biotechnology company committed to delivering a new class of differentiated one-time curative genetic therapies, today announced the closing of its underwritten public offering of 41,071,428 shares of its common stock, which includes the full exercise of the underwriters’ option to purchase 5,357,142 additional shares of its common stock, at a public offering price of $3.50 per share. All of the shares of common stock in the offering were sold by Prime Medicine. The gross proceeds to Prime Medicine from the offering, before deducting underwriting discounts and commissions and offering expenses, were a

MIAMI, Nov. 12, 2026 (GLOBE NEWSWIRE) -- InspireMD, Inc. (NASDAQ:NSPR) ("InspireMD" or the "Company"), developer of the CGuard® Prime carotid stent system for the prevention of stroke, today announced that it has commenced a proposed public offering of (i) shares of its common stock, (ii) in lieu of common stock to certain investors, pre-funded warrants to purchase shares of its common stock, and (iii) accompanying common warrants to purchase shares of its common stock or pre-funded warrants in lieu thereof to purchase shares of its common stock. All securities in the proposed offering are being offered by InspireMD. In addition, the Company intends to grant the underwriters a 30-day opti

IntentKey’s Privacy-By-Design Value Proposition Resonates as Sales Pipeline Builds Legacy Search Revenue Stabilizes Management to host conference call at 4:15 PM ET, Thursday, November 12, 2026 LITTLE ROCK, Ark., Nov. 12, 2026 (GLOBE NEWSWIRE) -- Inuvo, Inc. (NYSE:INUV), a provider of artificial intelligence-driven solutions for modeling media audiences, today announced financial results for the third quarter and nine months ended September 30, 2026, and provided a business update. Recent Business Highlights Audience Modeling Revenue Down While Pipeline Builds: Third quarter Audience Modeling revenue was 24% lower year-over-year while our sales pipeline expanded across automotive, tr

Vir Biotechnology, Inc. (NASDAQ:VIR), a clinical-stage biopharmaceutical company focused on powering the immune system to transform lives by discovering and developing medicines for serious infectious diseases and cancer, today announced that it intends to offer shares of its common stock in an underwritten public offering. In addition, Vir Biotechnology intends to grant the underwriters a 30-day option to purchase up to an additional 15% of the number of shares of its common stock to be sold in the offering at the public offering price, less underwriting discounts and commissions. All of the shares in the proposed offering will be offered by Vir Biotechnology. The proposed offering is subje

Record GAAP revenue of $210.8 millionRecord Core revenue of $230.9 millionGAAP cloud revenue grew 265% from a year agoCore cloud revenue $144.9 million, up 272% from a year agoCommercial wins with two new hyperscalers700 megawatts of data center capacity now under contractFirst to deliver production scale heterogeneous disaggregated inference offering SUNNYVALE, Calif., Nov. 12, 2026 (GLOBE NEWSWIRE) -- Cerebras Systems (NASDAQ:CBRS), maker of the world’s fastest AI infrastructure, today announced financial results for the third quarter ended September 30, 2026. "Cerebras’ technology remains the undisputed champion of speed," said Andrew Feldman, co-founder and CEO of Cerebras. "We’re gi

Product revenue grew 24% to $5.7 million, driven by strong software licensing performance; gross margin reached 90% for the second consecutive quarter Measurable results validate ROC’s core growth drivers; ROC ABIS grew 654% YoY to $2.2M and ROC SDK grew 52% YoY to $2.6M Secured transformational federal beachhead contracts for ROC ABIS and ROC Evidence, including a $64.3 million Department of Justice digital evidence contract award, the largest in Company history DENVER, Nov. 12, 2026 (GLOBE NEWSWIRE) -- Rank One Computing Corporation d/b/a ROC (NASDAQ:ROC) ("ROC" or the "Company"), a U.S. leader in Vision AI, building unified biometric, video analytics, and digital evidence solutions,

Third Quarter 2026 Business Highlights Revenue grew 65.9% year over year to $202.2 million.Bookings of $768.9 million, an increase of 364% year over year.Backlog of $1.7 billion, an increase of 329% and 51.0% over prior year and prior quarter, respectively.Book-to-bill ratio of 3.8x.Net income was $3.2 million, a decline of $10.5 million; net income margin was 1.6%.Adjusted net income* was $20.9 million, a decline of 7.0%.Adjusted EBITDA* increased by $8.9 million to $37.7 million; Adjusted EBITDA margin* was 18.7%.Operating cash flow increased to $62.5 million from an outflow of $0.6 million in the prior year.Subsequent to quarter end, the Company entered into a new $650 million senior sec

Record Collections Grow 35% to $319.2 Million and Deployments grow 111% to $318.0 MillionRecord Estimated Remaining Collections ("ERC") up 23% to $3.6 BillionPre-tax Income of $58.9 Million with Net Income of $46.9 Million and EPS of $0.76Adjusted Pre-tax Income of $63.3 Million with Adjusted Net Income of $51.3 Million and Adjusted EPS of $0.83Board of Directors Declares Quarterly Cash Dividend of $0.24 per Share MINNEAPOLIS, Nov. 12, 2026 (GLOBE NEWSWIRE) -- Jefferson Capital, Inc. ("Jefferson Capital, the "Company"), a leading analytically driven purchaser and manager of charged-off, insolvency and active consumer accounts, today announced its third quarter 2026 financial results. Thi

NEW YORK, Nov. 12, 2026 (GLOBE NEWSWIRE) -- TMC the metals company Inc. (NASDAQ:TMC) ("TMC" or "the Company"), a leading developer of the world’s largest resource of critical metals essential to energy, defense, manufacturing and infrastructure, today provided a corporate update and third quarter financial results for the period ended September 30, 2026. Q3 2026 Financial Highlights Liquidity of approximately $123 million available from our cash on hand and our credit facilities as of September 30, 2026$19.4 million cash used in operations for the quarter ended September 30, 2026Net loss of $28.4 million and net loss per share of 6 cents for the quarter ended September 30, 2026 TM

Management to host conference call and webcast today at 4:30 p.m. ETLEXINGTON, Mass., Nov. 12, 2026 /PRNewswire/ -- Curis, Inc. (NASDAQ:CRIS), a biotechnology company focused on the development of emavusertib (CA-4948), an orally available, small molecule IRAK4 and FLT3 inhibitor, today reported its financial and operating results for the third quarter ended September 30, 2026. "We are encouraged by our progress in both the TakeAim CLL study and the TakeAim Lymphoma study," said James Dentzer, Chief Executive Officer of Curis. "The excitement among clinicians and patients reflects the clear unmet need in both CLL and PCNSL, whe

ERAS-0015 granted FDA Fast Track Designation for metastatic pancreatic adenocarcinoma; advancing toward three potentially registration-enabling trials in pancreatic and lung cancers Updated ERAS-0015 monotherapy and nonclinical ERAS-0015/ERAS-4001 combination data to be presented at ENA; expect preliminary ERAS-4001 data in H2 2026 and ERAS-0015 data in H1 2027 Cash, cash equivalents, and marketable securities of $948 million as of September 30, 2026 SAN DIEGO, Nov. 12, 2026 (GLOBE NEWSWIRE) -- Erasca, Inc. (NASDAQ:ERAS), a clinical-stage precision oncology company singularly focused on discovering, developing, and commercializing therapies for patients with RAS/MAPK pathway-driven canc

CAMBRIDGE, Mass., Nov. 12, 2026 (GLOBE NEWSWIRE) -- Akamai Technologies, Inc. (NASDAQ:AKAM) ("Akamai") today announced that it has closed its previously announced private offering of $1.25 billion in aggregate principal amount of 1.00% convertible senior notes due 2028 (the "2028 Notes") and $1.25 billion in aggregate principal amount of 1.00% convertible senior notes due 2031 (the "2031 Notes" and, together with the 2028 Notes, the "notes") to persons reasonably believed to be "qualified institutional buyers" pursuant to Rule 144A under the Securities Act of 1933, as amended (the "Securities Act"). The aggregate principal amount of each series of notes includes $150.0 million issued pursu

Initiated the Company’s third Phase 1b clinical trial, BActinium-2, broadening the evaluation of AKY-2519 to lung cancer and other B7-H3 expressing tumorsStarted first backfill cohorts in the ongoing Phase 1b NECTINIUM-2 clinical trial of AKY-1189 and Phase 1b BActinium-1 clinical trial of AKY-2519On track to present preliminary data for AKY-1189 in first quarter of 2027 and AKY-2519 in 2027 BOSTON, Nov. 12, 2026 (GLOBE NEWSWIRE) -- Aktis Oncology, Inc. (NASDAQ:AKTS) ("Aktis" or the "Company"), a clinical-stage oncology company focused on expanding the breakthrough potential of targeted radiopharmaceuticals to large populations, today reported financial results for the third quarter end

The AI Brain for Batteries™ platform goes trackside as ELECTRA AI races as the Official Battery Intelligence Partner, with its branding on the team's RaceBird ELECTRA AI ("ELECTRA"), the AI Brain for Batteries™ platform, and Iron Horse Acquisition II Corp. (NASDAQ:IRHO) ("Iron Horse") today announced that ELECTRA AI races as the Official Battery Intelligence Partner of Westbrook Racing by Visit Angola at the E1 Miami GP 2026, November 11–14. ELECTRA AI branding debuts on the team's RaceBird, bringing the company's battery intelligence from the data room to the water. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20261112605001/

FRISCO, Texas and BURLINGTON, Mass., Nov. 12, 2026 /PRNewswire/ -- Keurig Dr Pepper Inc. (NASDAQ:KDP) ("KDP" or the "Company") today announced that it has commenced an underwritten public offering of $2.0 billion of shares of its common stock, par value $0.01 per share (the "Offering"). KDP's common stock is listed on the Nasdaq Global Select Market under the symbol "KDP."KDP intends to grant the underwriters of the Offering a 30-day option to purchase up to an additional $300 million of shares of common stock, at the same price per share as the other shares of common stock purchased by the underwriters in the Offering. The Offering is subject to market and other customary conditions.Consist

SHOEMAKERSVILLE, Pa., Nov. 12, 2026 (GLOBE NEWSWIRE) -- Hydrofarm Holdings Group, Inc. ("Hydrofarm" or the "Company") (NASDAQ:HYFM) today announced that it has received confirmation from The Nasdaq Stock Market LLC ("Nasdaq") by letter dated November 9, 2026, that the Company has regained compliance with Nasdaq Listing Rule 5550(b)(1), the $2.5 million minimum stockholders’ equity requirement for continued listing on The Nasdaq Capital Market (the "Equity Rule"). "We received notice from Nasdaq that we are in compliance on our stockholders’ equity, another milestone in our financial restructuring," said Bill Toler, Chairman and Chief Executive Officer. "With this confirmation, our organiz

ATLANTA, Nov. 12, 2026 /PRNewswire/ -- Southern Company (NYSE:SO) today announced it plans to sell 35 million equity units in a public offering. Each equity unit will be issued in a stated amount of $50 ($1.75 billion aggregate stated amount) and will consist of a contract to purchase Southern Company common stock in the future and two 1/40 undivided beneficial ownership interests in remarketable senior notes each having a principal amount of $1,000. Southern Company expects to grant to the underwriters an option to purchase an additional 5 million equity units ($250 million aggregate stated amount) solely for the purpose of covering over-allotments.

Total Contract Backlog More Than Doubles to $577.2 Million and Funded Backlog Nearly Doubles to $119.6 Million; Company Completes First Commercial Reactor Core Delivery Total Contract Backlog* of $577.2 million at September 30, 2026, up from $241.5 million at June 30, 2026, with Funded Backlog nearly doubling to $119.6 million from $61.9 million; Total Contract Backlog and Qualified Pipeline together of approximately $1.4 billion In August 2026, executed a fuel supply agreement with Antares Nuclear, Inc. ("Antares") for a firm commitment of one metric ton of uranium contained in HALEU TRISO fuel (MTU), plus a customer option for up to seven additional MTU Completed delivery of th

SHENZHEN, China, Nov. 12, 2026 (GLOBE NEWSWIRE) -- Xunlei Limited ("Xunlei" or the "Company") (NASDAQ:XNET), a leading technology company providing distributed cloud services in China, today announced its unaudited financial results for the third quarter ended September 30, 2026. Third Quarter 2026 Financial Highlights (results presented herein exclude Shenzhen Onething, discontinued operations, unless specified otherwise1) Total revenues were US$101.3 million, representing an increase of 12.9% year-over-year. Subscription revenues were US$44.1 million, representing an increase of 8.5% year-over-year. Live-streaming and other services revenues were US$57.2 million, representing an incr

CareTrust REIT, Inc. (NYSE:CTRE) ("CareTrust REIT" or the "Company") announced the pricing of an underwritten public offering of an aggregate of 17,000,000 shares of its common stock sold on a forward basis in connection with the forward sale agreements described below, for gross proceeds of approximately $637.5 million. The underwriters may also purchase up to an additional 2,550,000 shares of the Company’s common stock within 30 days from the date of the prospectus supplement relating to the offering. The offering is expected to close on November 13, 2026 subject to customary closing conditions. BofA Securities, Morgan Stanley, J.P. Morgan and Wells Fargo Securities acted as book-runnin

PepGen Inc. (NASDAQ:PEPG), a clinical-stage biotechnology company pioneering oligonucleotide therapies with the potential to transform the treatment of rare genetic diseases, today announced the pricing of a public offering of 25,000,000 shares of its common stock at a price to the public of $5.00 per share. The aggregate gross proceeds to PepGen from this offering are expected to be $125 million, before deducting underwriting discounts and commissions and offering expenses payable by PepGen. In addition, PepGen has granted the underwriters a 30-day option to purchase up to an additional 3,750,000 shares of common stock at the public offering price, less the underwriting discounts and commi

New York, Nov. 11, 2026 (GLOBE NEWSWIRE) -- Univest Securities, LLC ("Univest"), a member of FINRA and SIPC, and a full-service investment bank and securities broker-dealer firm based in New York, today announced the closing of a registered direct offering (the "Offering") of $3.5 million for its client Lichen International Limited (NASDAQ:LICN) (the "Company"), a dedicated financial and taxation service provider in China. Under the terms of the securities purchase agreement, the Company has agreed to sell to certain institutional investors an aggregate of 17,500,000 units (each, a "Unit"), consisting of one Class A Ordinary Share of the Company (or one pre-funded warrant in lieu thereof)

AEVEX Corp. (NYSE:AVEX) ("AEVEX" or the Company) announced results today for the three months ended September 30, 2026 ("Third Quarter 2026"). Total revenue of $189.7 million, up 56.5% from $121.2 million in Q3 2025 Net loss of $16.8 million compared to net income of $9.9 million in Q3 2025 Adjusted EBITDA* of $30.8 million compared to Adjusted EBITDA* of $17.8 million in Q3 2025 Completed the acquisition of BlackSea Technologies on September 8, 2026, establishing Maritime Systems as AEVEX’s third reportable segment Raised Outlook for Full Year 2026 Total revenue of $820.0 million to $840.0 million, compared to our prior range of $700.0 million to $720.0 million Adjuste

CareTrust REIT, Inc. (NYSE:CTRE) ("CareTrust REIT" or the "Company") announced that it has commenced, subject to market and other conditions, an underwritten public offering of an aggregate of 17,000,000 shares of its common stock in connection with the forward sale agreements described below.BofA Securities, Morgan Stanley, J.P. Morgan and Wells Fargo Securities are acting as the book-running managers for the offering.In connection with the offering of shares of its common stock, the Company expects to enter into separate forward sale agreements with each of Bank of America, N.A. and Morgan Stanley (or their respective affiliates), each referred to in such capacity as a forward purchaser. T

AUBURN HILLS, Mich., Nov. 11, 2026 /PRNewswire/ -- Custom Jeep® Wrangler Commando 392 to be auctioned exclusively to the public, with proceeds benefiting the USOFinal Jeep Wrangler Commando is the only public offering from a limited 250-unit program; 249 were reserved for active-duty military personnel and veteransOnline auto auction opens Nov. 11 and closes Nov. 22 on Bring a TrailerThe Jeep® brand, FOX Factory Vehicles and the USO announce the auction of a customized Jeep Wrangler Commando 392. The exclusive Jeep Wrangler Commando will be auctioned on Bring a Trailer from Nov. 11-22, with 100% of the proceeds benefiting the U

OSAKA, Japan, Nov. 11, 2026 (GLOBE NEWSWIRE) -- TryHard Holdings Limited ("TryHard" or the "Company") (NASDAQ:THH), a lifestyle entertainment platform in Japan, today announced that its wholly owned subsidiary, TryHard Japan Co., Ltd. ("TryHard Japan"), successfully operated a drone light show reportedly the largest in Japan, featuring 4,050 drones at the 2026 Saga International Balloon Fiesta on November 3, 2026, along the banks of the Kase River in Saga City, Japan. According to the event organizer, the performance attracted approximately 50,000 spectators, and featured synchronized drone formations accompanied by a live violin performance. The drone show was operated by TryHard Japan,

Greenwich, CT, Nov. 11, 2026 (GLOBE NEWSWIRE) -- Southport Acquisition Corp. II (NYSE:PORT) (the "Company") announced today that, commencing November 16, 2026, holders of the units sold in the Company’s initial public offering may elect to separately trade the Company’s Class A ordinary shares and warrants included in the units. The Class A ordinary shares and warrants that are separated will trade on the New York Stock Exchange under the symbols "PORT" and "PORT WS," respectively. Those units not separated will continue to trade on the New York Stock Exchange under the symbol "PORT U." This press release shall not constitute an offer to sell or the solicitation of an offer to buy the sec

MALVERN, Pa., Nov. 10, 2026 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ:STIM) (the "Company") today announced the pricing of its previously announced underwritten public offering of its common stock, comprised of 18,750,000 shares of common stock at a public offering price of $1.60 per share. The gross proceeds to the Company from this offering are expected to be approximately $30 million, before deducting underwriting discounts and commissions and other offering expenses payable by the Company. The Company also granted the underwriters a 30-day option to purchase up to an additional 2,812,500 shares of common stock at the public offering price per share, less underwriting discounts and

CAMBRIDGE, Mass., Nov. 10, 2026 (GLOBE NEWSWIRE) -- Prime Medicine, Inc. (NASDAQ:PRME), a biotechnology company committed to delivering a new class of differentiated one-time curative genetic therapies, today announced the pricing of an underwritten public offering of 35,714,286 shares of its common stock at a public offering price of $3.50 per share. Prime Medicine has also granted the underwriters a 30-day option to purchase up to an additional 5,357,142 shares of its common stock. The gross proceeds to Prime Medicine from the offering, before deducting underwriting discounts and commissions and offering expenses, are expected to be approximately $125.0 million, excluding any exercise of

TRAVERSE CITY, Mich., Nov. 10, 2026 /PRNewswire/ -- Hagerty, Inc. (NYSE:HGTY) ("Hagerty"), a business that makes it easier and more enjoyable to be a driving enthusiast, announced the pricing of its secondary offering, upsized to 10,000,000 shares of Hagerty's Class A Common Stock, being offered by Hagerty Holding Corp. ("HHC" or the "Selling Stockholder") at a price to the public of $14.85 per share. In connection with the offering, the Selling Stockholder also granted the underwriters a 30-day option to purchase up to an additional 1,500,000 shares of Hagerty's Class A Common Stock. The offering is expected to close on or about November 12, 2026, subject to the satisfaction of customary cl

New York, Nov. 10, 2026 (GLOBE NEWSWIRE) -- Univest Securities, LLC ("Univest"), a member of FINRA and SIPC, and a full-service investment bank and securities broker-dealer firm based in New York, today announced the closing of a registered direct offering (the "Offering") of $1.2 million for its client JIADE LIMITED (NASDAQ:JDZG) (the "Company" or "JIADE"), a provider of one-stop comprehensive education support services for adult education institutions through its subsidiaries in the People's Republic of China. Under the terms of the securities purchase agreement, the Company has agreed to sell to an institutional investor 6,666,666 Class A Ordinary Shares of the Company (or pre-funded w

Updated filing and investor presentation mark continued progress toward ELECTRA's Nasdaq listing Electra Vehicles, Inc. ("ELECTRA AI" or "ELECTRA"), the AI Brain for Batteries™ platform, and Iron Horse Acquisition II Corp. (NASDAQ:IRHO) ("Iron Horse") today announced the filing of Amendment No. 1 to the Registration Statement on Form S-4 (as amended, the "Registration Statement") with the U.S. Securities and Exchange Commission (the "SEC") in connection with their previously announced proposed business combination (the "Business Combination") pursuant to the Merger Agreement, dated as of April 21, 2026, as amended on May 14, 2026 (the "Merger Agreement"). The Registration Statement refl

All table references in thousands of Canadian dollars, except per share amounts, unless otherwise indicated Altius Minerals Corporation (TSX:ALS, OTCQX:ATUSF) ("Altius" or the "Corporation") reports its third quarter revenue of $19.6 million compared to $17.2 million in Q3 2025. Net earnings of $10.1 million ($0.17 per share) compares to net earnings of $264.9 million ($5.72 per share) in Q3 2025. Q3 2026 net earnings reflect higher revenues and higher expenses including costs of sales, general and administrative, share based compensation and amortization. In Q3 2025 the Corporation recognized a gain on sale of 2/3 of its Arthur Gold royalty. Q3 2026 attributable royalty revenue(1) of $

Revenue totaled $664,000, with Sales Growing by 130% Certified Partner Network Expands 50% to 31 Operators HexiTech Joint Venture Successfully Passes Burn Testing Across Multiple Wood Species CitroTech-31 Named to TIME’s Best Inventions of 2026 Company Completes $5.6 Million Public Offering with Strong Insider Participation CitroTech Inc. (NYSE AM: CITR), a leading specialty chemical company delivering environmentally safe fire inhibitor solutions, today reported third quarter financial highlights and provided a comprehensive business update in a letter to shareholders from CEO Wes Bolsen, detailing 130% year-over-year revenue growth and accelerating commercial adoption across mul

PepGen Inc. (NASDAQ:PEPG), a clinical-stage biotechnology company pioneering oligonucleotide therapies with the potential to transform the treatment of rare genetic diseases, today announced the launch of a public offering of $125.0 million of shares of its common stock and, in lieu of common stock to certain investors, pre-funded warrants to purchase shares of its common stock. In addition, PepGen intends to grant the underwriters a 30-day option to purchase up to an additional $18.75 million of shares of its common stock the securities to be sold in the proposed offering at the public offering price, less underwriting discounts and commissions. All of the securities to be sold in the prop

NEW YORK, Nov. 10, 2026 /PRNewswire/ -- Ares Dynamic Credit Allocation Fund, Inc. ("ARDC" or the "Fund") (NYSE:ARDC) announced today the declaration of its distribution for the month of November 2026 of $0.1125 per common share, payable as noted below. The following dates apply to the declared distribution:Ex-Date: November 20, 2026Record Date: November 20, 2026Payable Date: November 30, 2026Per Share Amount: $0.1125Based on the Fund's current share price of $11.64 (as of its close on November 9, 2026), the distribution represents an annualized distribution rate of approximately 11.60% (calculated by annualizing the distribution amount and dividing it by the current price). Information regar

TORONTO, Nov. 10, 2026 (GLOBE NEWSWIRE) -- Barrick Mining Corporation (NYSE:B)(TSX:ABX) ("Barrick" or the "Company") today announced that its planned new publicly listed company, which will hold Barrick’s North American gold assets, will be named American Barrick Gold Corporation ("American Barrick"). The Company is moving forward with the proposed initial public offering ("IPO") of American Barrick common stock. American Barrick has filed a registration statement on Form S-11 with the U.S. Securities and Exchange Commission ("SEC") in connection with the proposed IPO. American Barrick intends to apply to list its common stock on the New York Stock Exchange under the ticker symbol ‘ABGC’.

Preliminary third quarter net sales of $2.12 billion to $2.13 billion, net income of $128 million to $140 million and Adjusted EBITDA (Non-GAAP) of $267 million to $275 million Maintains fiscal 2026 net sales outlook and updates Adjusted EBITDA (Non-GAAP) outlook to $950 million to $960 million, from $950 million to $980 million Completes three acquisitions with over $250 million in combined annual revenue Repurchases a quarterly record $171 million of shares Core & Main, Inc. (NYSE:CNM) ("Core & Main" or the "Company"), a leading specialty distributor dedicated to advancing reliable infrastructure with local service, nationwide, today announced, in advance of its participat

BrightView Holdings, Inc. (NYSE:BV) (the "Company" or "BrightView"), the leading commercial landscaping services company in the United States, today reported unaudited results for the three months and full fiscal year ended September 30, 2026. Fourth quarter net service revenue decreased 3.6% year-over-year to $677.3 million, Fourth quarter Maintenance Services revenue increased 3.2% year-over-year to $495.7 million, Fourth quarter Development Services revenue decreased 17.8% year-over-year to $184.2 million, Full year net service revenue increased 1.5% year-over-year to $2.7 billion, Full year Maintenance Services revenue increased 6% year-over-year to $2.0 billion, includin

TRAVERSE CITY, Mich., Nov. 10, 2026 /PRNewswire/ -- Hagerty, Inc. (NYSE:HGTY) ("Hagerty"), a business that makes it easier and more enjoyable to be a driving enthusiast, announced that Hagerty Holding Corp. ("HHC" or the "Selling Stockholder") intends to offer 9,000,000 shares of Hagerty's Class A Common Stock in an underwritten secondary public offering. In connection with the offering, the Selling Stockholder also intends to grant the underwriters a 30-day option to purchase up to an additional 1,350,000 shares of Hagerty's Class A Common Stock. Hagerty will not receive any proceeds from the sale of shares of its Class A Comm

CAMBRIDGE, Mass., Nov. 10, 2026 (GLOBE NEWSWIRE) -- Prime Medicine, Inc. (NASDAQ:PRME), a biotechnology company committed to delivering a new class of differentiated one-time curative genetic therapies, today announced that it has commenced an underwritten public offering of $125.0 million of shares of its common stock. Prime Medicine also intends to grant the underwriters a 30-day option to purchase up to an additional $18.75 million of shares of its common stock. All of the shares of common stock in the proposed offering are to be sold by Prime Medicine. The proposed offering is subject to market and other conditions, and there can be no assurance as to whether or when the offering may b

MALVERN, Pa., Nov. 10, 2026 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ:STIM) (the "Company" or "Neuronetics"), a leader in interventional mental health and provider of NeuroStar® TMS technology and direct patient care through the Greenbrook network of interventional psychiatry clinics, today announced that it has commenced an underwritten public offering of shares of its common stock. All of the shares of common stock in the proposed offering will be sold by Neuronetics. In addition, Neuronetics intends to grant the underwriters of the offering a 30-day option to purchase up to an additional 15% of the shares of common stock offered in the offering at the public offering price, less the

SEATTLE, Nov. 10, 2026 (GLOBE NEWSWIRE) --  Parabolic Technologies, Inc. (NASDAQ:PARA) (the "Company"), a leading AI-powered agentic applications technology company, today announced it deployed the $12.1 million proceeds from its recently closed public offering (after underwriting discounts and offering fees) primarily to pay off $11.6 million in debt obligations ahead of schedule, and to retire all warrants held by 3i, LP. The Company believes it now has sufficient operating cash to meet all its short term needs. The debt paydown was focused on four main obligations: Full payoff of our $5.1 million senior convertible note with CP BF Lending, LLC.Full payoff of our $4.6 million convertib

KOBE, Japan, Nov. 10, 2026 (GLOBE NEWSWIRE) -- Micware Co., Ltd. (NASDAQ:MWC) (the "Company" or "Micware"), a Japan-based provider of in-vehicle infotainment, navigation, and location-based software for automakers including Honda and Toyota, today announced its unaudited financial results for the six months ended August 31, 2026. Six Months Ended August 31, 2026 Financial Highlights Revenue was JPY10,612.7 million (US$66.4 million) for the six months ended August 31, 2026, an increase of 3.4% from JPY10,261.1 million for the six months ended August 31, 2025.Gross profit was JPY3,847.9 million (US$24.1 million) for the six months ended August 31, 2026, an increase of 19.5% from JPY3,220.5

HA Sustainable Infrastructure Capital, Inc. ("HASI," "our," "we," or the "Company") (NYSE:HASI), a leading investor in sustainable infrastructure assets, announced that yesterday, on November 9, 2026, it priced its registered public offering of $500 million in aggregate principal amount of 7.850% green junior subordinated notes due 2057 (the "Notes"). At issuance, the Notes will be guaranteed on a subordinated basis by Hannon Armstrong Sustainable Infrastructure, L.P., Hannon Armstrong Capital, LLC, HAT Holdings I LLC, HAT Holdings II LLC, HAC Holdings I LLC and HAC Holdings II LLC. The settlement of the Notes is expected to occur on November 24, 2026, subject to customary closing condition

CARLSBAD, Calif., Nov. 10, 2026 (GLOBE NEWSWIRE) -- Aptera Motors Corp. (NASDAQ:SEV) ("Aptera" or the "Company"), a solar mobility company advancing ultra-efficient transportation, today announced that it has entered into a definitive securities purchase agreement with institutional investors for the purchase and sale of 3,428,571 shares of the Company’s Class B common stock at an offering price of $1.75 per share in a registered direct offering. In addition, in a concurrent private placement, the Company will issue to the investors unregistered warrants to purchase up to 3,428,571 shares of Class B common stock in the aggregate. The warrants will have an exercise price of $2.05 per share

XIAMEN, China, Nov. 10, 2026 (GLOBE NEWSWIRE) -- Lichen International Limited (NASDAQ:LICN) (the "Company"), a dedicated financial and taxation service provider in China, today announced that it has entered into securities purchase agreements with certain institutional investors for the purchase and sale of an aggregate of 17,500,000 units (each, a "Unit"), consisting of one Class A Ordinary Share (or one pre-funded warrant in lieu thereof) and one warrant to purchase 4.72 Class A Ordinary Shares (each, a "Warrant"), at an offering price of $0.20 per Unit in a registered direct offering (the "Offering"). The gross proceeds to the Company from the registered direct offering are estimated

CITY-RBP4 is an RNAi therapeutic candidate designed to provide potent and durable suppression of RBP4, a clinically supported target in Stargardt disease City’s second program to advance into the clinic, demonstrating strong momentum across the pipeline CAMBRIDGE, Mass., Nov. 10, 2026 (GLOBE NEWSWIRE) -- City Therapeutics, Inc. (NASDAQ:CTY), a clinical-stage biotechnology company engineering the next generation of RNA interference (RNAi) therapeutics, today announced that the first participant has been dosed in the Phase 1 clinical trial of CITY-RBP4, an investigational RNAi therapeutic candidate for the treatment of Stargardt disease type 1 (Stargardt disease). CITY-RBP4 is designed to

New authorization reflects confidence in the Company's strategic transformation and long-term prospectsSINGAPORE, Nov. 10, 2026 /PRNewswire/ -- Canaan Inc. (NASDAQ:CAN) ("Canaan" or the "Company"), an innovator in compute and energy infrastructure, today announced the launch of an initial share repurchase program of up to US$20 million under a broader US$100 million share repurchase authorization approved by its board of directors (the "Board"). The overall authorization is valid for a 12-month period beginning November 6, 2026, upon the Board's approval, providing the Company with flexibility to consider additional repurchases within the authorized limit. Nangeng Zhang, chairman and chief e

SINGAPORE, Nov. 10, 2026 /PRNewswire/ -- Canaan Inc. (NASDAQ:CAN) ("Canaan" or the "Company"), an innovator in compute and energy infrastructure, today announced that it plans to change the ratio of its American depositary shares ("ADSs") to its Class A ordinary shares from the current ratio of one ADS representing 15 Class A ordinary shares to a new ratio of one ADS representing 375 Class A ordinary shares (the "ADS Ratio Change"), effective on or about December 4, 2026, U.S. Eastern Time (the "Effective Date"). For the Company's ADS holders, the ADS Ratio Change will have the same effect as a 1-for-25 reverse split of the ADSs. Upon the Effective Date, ADS holders will exchange every 25 ex

(See Glossary for Defined Terms on Page 9) TORONTO, Nov. 09, 2026 (GLOBE NEWSWIRE) -- McEwen Inc. (NYSE/TSX:MUX) ("McEwen" or the "Company") today announced its third quarter financial results for the period ended September 30, 2026 (Q3). During the quarter, the Company experienced lower production and higher costs. In the case of the Gold Bar Complex, this was due to poor management oversight and was the reason the Company decided to make changes to its leadership team in late August. New operating procedures have resulted in production rising and costs dropping in October, which the team believes can be sustained. At the Fox Complex, a combination of completing all future Froome

SmartStop Self Storage REIT, Inc. ("SmartStop") (NYSE:SMA), a self-managed real estate investment trust and a premier owner and operator of self-storage facilities in the United States and Canada, announced the pricing of an underwritten public offering of 8,150,000 shares of its common stock, par value $0.001 per share, at a public offering price of $37.00 per share, in connection with the forward sale agreements. The offering was upsized from the previously announced offering size of 7,000,000 shares of common stock and is expected to close on November 12, 2026, subject to customary closing conditions. J.P. Morgan, Wells Fargo Securities, KeyBanc Capital Markets, BMO Capital Markets and

NEW YORK, Nov. 9, 2026 /PRNewswire/ -- TEN Holdings, Inc. (NASDAQ:XHLD) (the "Company" or "TEN Holdings"), the technology company behind TEN, a Digital Experience Platform that powers the next generation of enterprise digital engagement, today announced the closing of its registered direct offering of an aggregate of 3,389,831 shares of the Company's common stock at a purchase price of $0.59 per share. The gross proceeds from the offering were approximately $2.0 million, before deducting offering expenses payable by the Company.The Company intends to use the net proceeds from the offering for working capital and general corpora

NEW YORK, Nov. 09, 2026 (GLOBE NEWSWIRE) -- Apollo Global Management, Inc. (NYSE:APO) (the "Issuer" and, together with its consolidated subsidiaries, "Apollo") today announced that it has priced an offering (the "Offering") of $600 million aggregate principal amount of its 7.550% Fixed-Rate Resettable Junior Subordinated Notes due 2056 (the "notes"). The notes will be fully and unconditionally guaranteed by certain subsidiaries of the Issuer that are obligors under the Issuer’s outstanding debt securities. The Offering is expected to close on November 13, 2026, subject to the satisfaction of customary closing conditions. The notes will bear interest at a fixed rate of 7.550% per annum un